Global Carcinoid Syndrome Diarrhea Treatment Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 90

Report ID: 1406

Carcinoid syndrome is a group of symptoms that can occur in patients suffering from carcinoid tumors which also called as metastatic neuroendocrine tumors. Carcinoid tumors are rare and these are slow growing tumors. Most of the tumors occur in gastrointestinal tract. According to FDA, carcinoid syndrome occurs in less than 10 percent of people suffering from carcinoid tumors, mostly after the tumor has spread to the liver. This syndrome causes overproduction of serotonin hormone which results in chronic diarrhea. Chronic diarrhea leads to malnutrition, weight loss, electrolyte imbalance and dehydration.
Carcinoid syndrome diarrhea is a rare condition. Treatment available for this condition are expected to get orphan drug status. Government and regulatory body support for development of orphan drug and incentives are expected to drive carcinoid syndrome treatment market. Government allow companies to set high price for the orphan drug and which in turn will generate high revenue. Ineffectiveness of diarrhea controlling agents in case of carcinoid syndromes diarrhea will also drive the growth of this market.
In 2018, the global Carcinoid Syndrome Diarrhea Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Carcinoid Syndrome Diarrhea Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Carcinoid Syndrome Diarrhea Treatment development in United States, Europe and China.

The key players covered in this study
Lexicon Pharmaceuticals
Novartis International
Pharmascience
Omega Laboratories
Teva Pharmaceutical Industries
Mylan
Ipsen
Sirtex Medical
BTG International

Market segment by Type, the product can be split into
Chemotherapy
Somatostatin Analog (SSA) Therapy
Oral Therapy

Market segment by Application, split into
Hospitals
Clinics
Cancer Research Institutes

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Carcinoid Syndrome Diarrhea Treatment status, future forecast, growth opportunity, key market and key players.
To present the Carcinoid Syndrome Diarrhea Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Carcinoid Syndrome Diarrhea Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Carcinoid Syndrome Diarrhea Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Chemotherapy
1.4.3 Somatostatin Analog (SSA) Therapy
1.4.4 Oral Therapy
1.5 Market by Application
1.5.1 Global Carcinoid Syndrome Diarrhea Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Cancer Research Institutes
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Carcinoid Syndrome Diarrhea Treatment Market Size
2.2 Carcinoid Syndrome Diarrhea Treatment Growth Trends by Regions
2.2.1 Carcinoid Syndrome Diarrhea Treatment Market Size by Regions (2014-2025)
2.2.2 Carcinoid Syndrome Diarrhea Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Carcinoid Syndrome Diarrhea Treatment Market Size by Manufacturers
3.1.1 Global Carcinoid Syndrome Diarrhea Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Carcinoid Syndrome Diarrhea Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Carcinoid Syndrome Diarrhea Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Carcinoid Syndrome Diarrhea Treatment Key Players Head office and Area Served
3.3 Key Players Carcinoid Syndrome Diarrhea Treatment Product/Solution/Service
3.4 Date of Enter into Carcinoid Syndrome Diarrhea Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Carcinoid Syndrome Diarrhea Treatment Market Size by Type (2014-2019)
4.2 Global Carcinoid Syndrome Diarrhea Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Carcinoid Syndrome Diarrhea Treatment Market Size (2014-2019)
5.2 Carcinoid Syndrome Diarrhea Treatment Key Players in United States
5.3 United States Carcinoid Syndrome Diarrhea Treatment Market Size by Type
5.4 United States Carcinoid Syndrome Diarrhea Treatment Market Size by Application

6 Europe
6.1 Europe Carcinoid Syndrome Diarrhea Treatment Market Size (2014-2019)
6.2 Carcinoid Syndrome Diarrhea Treatment Key Players in Europe
6.3 Europe Carcinoid Syndrome Diarrhea Treatment Market Size by Type
6.4 Europe Carcinoid Syndrome Diarrhea Treatment Market Size by Application

7 China
7.1 China Carcinoid Syndrome Diarrhea Treatment Market Size (2014-2019)
7.2 Carcinoid Syndrome Diarrhea Treatment Key Players in China
7.3 China Carcinoid Syndrome Diarrhea Treatment Market Size by Type
7.4 China Carcinoid Syndrome Diarrhea Treatment Market Size by Application

8 Japan
8.1 Japan Carcinoid Syndrome Diarrhea Treatment Market Size (2014-2019)
8.2 Carcinoid Syndrome Diarrhea Treatment Key Players in Japan
8.3 Japan Carcinoid Syndrome Diarrhea Treatment Market Size by Type
8.4 Japan Carcinoid Syndrome Diarrhea Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Carcinoid Syndrome Diarrhea Treatment Market Size (2014-2019)
9.2 Carcinoid Syndrome Diarrhea Treatment Key Players in Southeast Asia
9.3 Southeast Asia Carcinoid Syndrome Diarrhea Treatment Market Size by Type
9.4 Southeast Asia Carcinoid Syndrome Diarrhea Treatment Market Size by Application

10 India
10.1 India Carcinoid Syndrome Diarrhea Treatment Market Size (2014-2019)
10.2 Carcinoid Syndrome Diarrhea Treatment Key Players in India
10.3 India Carcinoid Syndrome Diarrhea Treatment Market Size by Type
10.4 India Carcinoid Syndrome Diarrhea Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Carcinoid Syndrome Diarrhea Treatment Market Size (2014-2019)
11.2 Carcinoid Syndrome Diarrhea Treatment Key Players in Central & South America
11.3 Central & South America Carcinoid Syndrome Diarrhea Treatment Market Size by Type
11.4 Central & South America Carcinoid Syndrome Diarrhea Treatment Market Size by Application

12 International Players Profiles
12.1 Lexicon Pharmaceuticals
12.1.1 Lexicon Pharmaceuticals Company Details
12.1.2 Company Description and Business Overview
12.1.3 Carcinoid Syndrome Diarrhea Treatment Introduction
12.1.4 Lexicon Pharmaceuticals Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2014-2019)
12.1.5 Lexicon Pharmaceuticals Recent Development
12.2 Novartis International
12.2.1 Novartis International Company Details
12.2.2 Company Description and Business Overview
12.2.3 Carcinoid Syndrome Diarrhea Treatment Introduction
12.2.4 Novartis International Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2014-2019)
12.2.5 Novartis International Recent Development
12.3 Pharmascience
12.3.1 Pharmascience Company Details
12.3.2 Company Description and Business Overview
12.3.3 Carcinoid Syndrome Diarrhea Treatment Introduction
12.3.4 Pharmascience Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2014-2019)
12.3.5 Pharmascience Recent Development
12.4 Omega Laboratories
12.4.1 Omega Laboratories Company Details
12.4.2 Company Description and Business Overview
12.4.3 Carcinoid Syndrome Diarrhea Treatment Introduction
12.4.4 Omega Laboratories Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2014-2019)
12.4.5 Omega Laboratories Recent Development
12.5 Teva Pharmaceutical Industries
12.5.1 Teva Pharmaceutical Industries Company Details
12.5.2 Company Description and Business Overview
12.5.3 Carcinoid Syndrome Diarrhea Treatment Introduction
12.5.4 Teva Pharmaceutical Industries Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2014-2019)
12.5.5 Teva Pharmaceutical Industries Recent Development
12.6 Mylan
12.6.1 Mylan Company Details
12.6.2 Company Description and Business Overview
12.6.3 Carcinoid Syndrome Diarrhea Treatment Introduction
12.6.4 Mylan Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2014-2019)
12.6.5 Mylan Recent Development
12.7 Ipsen
12.7.1 Ipsen Company Details
12.7.2 Company Description and Business Overview
12.7.3 Carcinoid Syndrome Diarrhea Treatment Introduction
12.7.4 Ipsen Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2014-2019)
12.7.5 Ipsen Recent Development
12.8 Sirtex Medical
12.8.1 Sirtex Medical Company Details
12.8.2 Company Description and Business Overview
12.8.3 Carcinoid Syndrome Diarrhea Treatment Introduction
12.8.4 Sirtex Medical Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2014-2019)
12.8.5 Sirtex Medical Recent Development
12.9 BTG International
12.9.1 BTG International Company Details
12.9.2 Company Description and Business Overview
12.9.3 Carcinoid Syndrome Diarrhea Treatment Introduction
12.9.4 BTG International Revenue in Carcinoid Syndrome Diarrhea Treatment Business (2014-2019)
12.9.5 BTG International Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details